Nick Morrison

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Replacement Therapy

Radiofrequency Ablation

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Mandy Wong, Kurosh Parsi, Kenneth Myers, Marianne De Maeseneer, Joseph A Caprini, Attilio Cavezzi, David Ewan Connor, Alun Huw Davies, Sergio Gianesini, Jean-Luc Gillet, Louis Grondin, Jean-Jérôme Guex, Claudine Hamel-Desnos, Nick Morrison, Giovanni Mosti, Alvaro Orrego, Partsch Hugo, Eberhard Rabe, Pauline Raymond-Martimbeau, Michel Schadeck, Roberto Simkin, Lorenzo Tessari, Paul K Thibault, Jorge H Ulloa, Mark Steven Whiteley, Takashi Yamaki, Steven Zimmet, Kurosh Parsi, Selene Vuong, Anes Yang, Lois Zhang
Sclerotherapy of lower limb veins: Indications, contraindications and treatment strategies to prevent complications - A consensus document of the International Union of Phlebology-2023. Phlebology (2023)
Eberhard Rabe, Hugo Partsch, Nick Morrison, Mark H Meissner, Giovanni Mosti, Christopher R Lattimer, Patrick H Carpentier, Sylvain Gaillard, Michael Jünger, Tomasz Urbanek, Juerg Hafner, Malay Patel, Stephanie Wu, Joseph Caprini, Fedor Lurie, Tobias Hirsch
Risks and contraindications of medical compression treatment - A critical reappraisal. An international consensus statement. Phlebology 35 (7) (2020)
Eberhard Rabe, Partsch Hugo, Nick Morrison, Mark H Meissner, Giovanni Mosti, Christopher R Lattimer, Patrick H Carpentier, Sylvain Gaillard, Michael Juenger, Tomasz Urbanek, Juerg Hafner, Malay Patel, Stephanie Wu, Joseph Caprini, Fedor Lurie, Tobias Hirsch
Response to letter to editor regarding: "Risks and contraindications of medical compression treatment - a critical reappraisal. An international consensus statement PHLEB-19-150.R1". Phlebology 35 (10) (2020)
Nick Morrison, Raghu Kolluri, Michael Vasquez, Monte Madsen, Andrew Jones, Kathleen Gibson
Comparison of cyanoacrylate closure and radiofrequency ablation for the treatment of incompetent great saphenous veins: 36-Month outcomes of the VeClose randomized controlled trial. Phlebology 34 (6) (2018)